| 2022-11-21 | Indaptus Therapeutics, Inc. INDP | CEO and Director | 9,600 0.122% | $1.90 | $18,240 | +5.25% | ||
| 2022-11-18 | Indaptus Therapeutics, Inc. INDP | CEO and Director | 400 0.0047% | $1.76 | $705 | +4.97% | ||
| 2022-09-08 | Indaptus Therapeutics, Inc. INDP | CEO and Director | 10,308 0.1329% | $2.80 | $28,862 | -29.85% | ||
| 2022-09-06 | Indaptus Therapeutics, Inc. INDP | CEO and Director | 8,632 0.1092% | $2.57 | $22,184 | -25% | ||
| 2022-06-06 | Indaptus Therapeutics, Inc. INDP | CEO and Director | 19,727 0.2371% | $2.63 | $51,882 | -28.68% | ||
| 2021-11-18 | Indaptus Therapeutics, Inc. INDP | CEO and Director | 11,187 0.2847% | $5.82 | $65,108 | -44.81% | ||
| 2021-09-14 | Indaptus Therapeutics, Inc. INDP | CEO and Director | 12,000 0.2842% | $7.00 | $84,000 | -43.28% | ||
| 2016-03-15 | Cocrystal Pharma, Inc. COCP | 294,118 0.0353% | $0.51 | $150,000 | -22.95% | |||
| 2016-03-04 | Travere Therapeutics, Inc. TVTX | director | 10,000 0.0282% | $15.31 | $153,129 | +24.34% | ||
| 2016-03-03 | Travere Therapeutics, Inc. TVTX | director | 20,000 0.0545% | $14.45 | $289,000 | +27.31% | ||
| 2015-12-23 | Cocrystal Pharma, Inc. COCP | 100,000 0.0151% | $0.58 | $57,870 | -3.64% | |||
| 2015-03-25 | Cocrystal Pharma, Inc. COCP | 163,043 0.0216% | $0.92 | $150,000 | -22.77% | |||
| 2014-12-11 | Cocrystal Pharma, Inc. COCP | 200,000 0.0151% | $0.23 | $45,610 | +88.64% | |||
| 2014-11-25 | Travere Therapeutics, Inc. TVTX | director | 30,000 0.1058% | $8.60 | $258,099 | +147.72% |